ArticlePharmacology research & perspectives2014

The in vivo efficacy and side effect pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long-acting β 2-adrenoceptor agonist in preclinical animal species.

Michael Salmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.